{"nctId":"NCT01545232","briefTitle":"Pragmatic, Randomized Optimal Platelet and Plasma Ratios","startDateStruct":{"date":"2012-08"},"conditions":["Trauma"],"count":680,"armGroups":[{"label":"1:1:1 Blood Transfusion Ratio","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: 1:1:1 Blood Transfusion Ratio"]},{"label":"1:1:2 Blood Transfusion Ratio","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: 1:1:2 Blood Transfusion Ratio"]}],"interventions":[{"name":"1:1:1 Blood Transfusion Ratio","otherNames":[]},{"name":"1:1:2 Blood Transfusion Ratio","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who require the highest trauma team activation at each participating center,\n* Estimated age of 15 years or older or greater than/equal to weight of 50 kg if age unknown,\n* Received directly from the injury scene,\n* Initiated transfusion of at least one unit of blood component within the first hour of arrival or during prehospital transport, and\n* Predicted to receive a MT by exceeding the threshold score of either the Assessment of Blood Consumption (ABC) score or the attending trauma physician's judgment criteria\n\nExclusion Criteria:\n\n* Received care (as defined as receiving a life saving intervention) from an outside hospital or healthcare facility (Procedures and care given at an outside health facility cannot be documented or controlled resulting in a high variability of standards of care and clinical outcomes.)\n* Moribund patient with devastating injuries and expected to die within one hour of Emergency Department (ED) admission\n* Prisoners, defined as those who have been directly admitted from a correctional facility\n* Patients requiring an emergency thoracotomy\n* Children under the age of 15 years or under 50 kg body weight if age unknown\n* Known pregnancy in the ED\n* Greater than 20% total body surface area (TBSA) burns\n* Suspected inhalation injury\n* Received greater than five consecutive minutes of cardiopulmonary resuscitation (CPR with chest compressions) in the pre-arrival or ED setting\n* Known Do Not Resuscitate (DNR) prior to randomization\n* Enrolled in a concurrent, ongoing interventional, randomized clinical trial\n* Patients who have activated the \"opt-out\" process or patients/legally authorized representatives that refuse blood products on arrival to ED.","healthyVolunteers":false,"sex":"ALL","minimumAge":"15 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"24-hour Mortality","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43","spread":null},{"groupId":"OG001","value":"58","spread":null}]}]}]},{"type":"PRIMARY","title":"30-day Mortality","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"75","spread":null},{"groupId":"OG001","value":"89","spread":null}]}]}]},{"type":"PRIMARY","title":"Coagulation as Indicated by Number of Participants With Reported Venous Thrombolic Events (VTE)","description":"Blood samples were collected at time of ED admission and over time to determine the incidence of reported venous thrombolic events (VTE).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45","spread":null},{"groupId":"OG001","value":"42","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospital Free Days","description":null,"paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Hemostasis","description":"Time to hemostasis refers to the time that the subject achieved hemorrhage control (anatomic hemostasis and resuscitation complete)following emergency department (ED) arrival.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"105","spread":null},{"groupId":"OG001","value":"100","spread":null}]}]}]},{"type":"SECONDARY","title":"Amount of Randomized Blood Products Given to Hemostasis","description":null,"paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]}]},{"type":"SECONDARY","title":"Functional Status at Time of Hospital Discharge","description":"The Glasgow Outcome Extended Score (GOSE) is a tool used to measure recovery following brain injury and assists with prediction of long-term rehabilitation. The 8 scoring categories are death, vegetative state, lower severe disability, upper severe disability, lower moderate disability, upper moderate disability, lower good recovery and upper good recovery. A higher GOSE score correlates with better outcome.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"4.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Primary Surgical Procedure","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"290","spread":null},{"groupId":"OG001","value":"284","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Transfusion Related Serious Adverse Events","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Initial Hospital Discharge Status","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"118","spread":null},{"groupId":"OG001","value":"105","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"82","spread":null},{"groupId":"OG001","value":"77","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"59","spread":null},{"groupId":"OG001","value":"71","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75","spread":null},{"groupId":"OG001","value":"89","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Ventilator Free Days","description":null,"paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"ICU Free Days","description":null,"paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Amount of Blood Products Given From Hemostasis to 24 Hours After ED Admission","description":null,"paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":338},"commonTop":["Systemic inflammatory response syndrome","Infection","Sepsis","Acute Kidney Injury","Ventilator-associated pneumonia"]}}}